Report Categories
View AllRecent Articles
View All
Root ROOT Stock Is It Overvalued Root swings to surprise profit on massive EPS beat
Atlassian Corporation TEAM Stock Entry Signals 541 20260420
Why is VisionWave Holdings VWAV stock gaining attention recently Plummets 20260420
Expand EXE Stock Pattern Formation Review Momentum Fading 20260420
EWCZ European posts 634 percent Q4 2025 EPS beat as its shares end the trading session unchanged
ROCK Gibraltar Industries posts narrow Q4 2025 EPS beat shares rise 076 percent in todays trading
NTES NetEase EPS misses by 24 despite revenue growth shares slip
VNMEU Vendome reports quiet quarter with no material developments investors await next acquisition target announcement
Lucid Group Inc LCID Strategic Pivot to Affordable EV Segment Signals Volume Growth Ambitions Amid Q1 Revenue Miss
US Retail Sales Hold Steady in April Matching Estimates at 05
Japans Defense Ministry to Pilot Perovskite Solar Technology at Military Installations
Immunome IMNM Flat at 2079 Consolidation Continues 20260518
US Treasury Settles Sanctions Case Against Adani Enterprises Providing Legal Relief for Billionaire Gautam Adani
Intuit Announces 17 Workforce Reduction as Growth Concerns Mount Amid AI Disruption
Mango Faces Leadership Uncertainty as Founders Son Arrested in Fatal Cliff Incident
ixigo Partners with Uber and redBus to Integrate Cab and Bus Bookings into Trains App
Apollo Micro Systems Shares Rally 22 After Strong Quarterly Results
Dolly Varden Silver Corporation Q4 2025 Earnings Exploration Progress Overshadowed by WiderThanExpected Loss
DFDV Q1 2026 Earnings EPS Miss Sends Stock Lower Amid Weak Performance
Compugen Ltd Q1 2026 Earnings Narrowing Losses but Misses Estimates
Blackstone Mortgage Trust BXMT Q1 2026 Earnings EPS Falls Short Amid Challenging Credit Environment
CGTX Q1 2026 Earnings Narrower Loss Exceeds Estimates as PreRevenue Biotech Advances Pipeline
Akari Therapeutics AKTX Dips 25 Holding Above Critical Support Level
Roman DBDR Acquisition Corp II Unit DRDBU Holds Steady at 1052 as Support Levels Are Tested
Novartis NVS Holds Gains Near 151 as Pharmaceutical Sector Shows Stability
Laureate Education LAUR Gains 127 Approaches Key Resistance Zone